AS1810722
AS1810722 is an orally active and potent STAT6 inhibitor (IC50 :1.9 nM) . AS1810722 shows a good profile of CYP3A4 inhibition. AS1810722, a derivative of fused bicyclic pyrimidine, has the potential for allergic diseases such as asthma and atopic diseases research.
Product Specifications
CAS Number
909561-15-5
Purity
>98% (HPLC)
Solubility
DMSO : 62.5 mg/mL (130.89 mM; Need ultrasonic)
Smiles
O=C (N) CN1CCN (C2=CC=C (NC3=NC=C4C (N (CC5=CC (F) =CC (F) =C5) C=C4) =N3) C=C2) CC1
Molecular Formula
C25H25F2N7O
Molecular Weight
477.52
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC682946-100 1x 100 µL
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNCB2353-500 1x 500 µL
Calcineurin A / PPP3CA (CALNA/2353), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNUB2672-100 1x 100 µL
CD117 / c-Kit (Marker for Gastrointestinal Stromal Tumors) (KIT/2672), 0.2mg/mL
Sign In for Pricing
View Details 
BNUM1780-50 1x 50 µL
CD8A (Cytotoxic- & Suppressor T-Cell Marker) (N/A), 1mg/mL
Sign In for Pricing
View Details 
BNCB1725-500 1x 500 µL
Glycophorin A / CD235a (Erythrocyte Marker) (GYPA/1725R), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details